Diabetic neuropathy: cellular mechanisms as therapeutic targets. - Wikidata - awgldk - TriplyDB

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

http://www.wikidata.org/entity/Q37930962

about

Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Diabetic neuropathy: one disease or two?New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism Linking uric acid metabolism to diabetic complications Toxic stress, inflammation and symptomatology of chronic complications in diabetes Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions Animal models of peripheral neuropathies The effects of obesity on skeletal muscle regeneration Elevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelination Methylglyoxal evokes pain by stimulating TRPA1 The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.Schwann cell interactions with axons and microvessels in diabetic neuropathy.Modulation of C. elegans touch sensitivity is integrated at multiple levels.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Hyperglycemia, a neglected factor during cancer progression Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy Four-year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model.Iron homeostasis in peripheral nervous system, still a black box?Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons Diabetic neuropathy: clinical manifestations and current treatments.Inflammation in the pathogenesis of microvascular complications in diabetes.Treatment of painful diabetic neuropathy Burning through the pain: treatments for diabetic neuropathy.Ginsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.Bone marrow-derived TNF-α causes diabetic neuropathy in mice.Enriching the diet with menhaden oil improves peripheral neuropathy in streptozotocin-induced type 1 diabetic rats.Association of chronic diabetes and hypertension in sural nerve morphometry: an experimental study Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: a systematic review and a meta-analysis of Chinese studies Macrophages in diabetic gastroparesis--the missing link?The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy.Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth.Streptozotocin Stimulates the Ion Channel TRPA1 Directly: INVOLVEMENT OF PEROXYNITRITE Diabetic peripheral neuropathy in type 2 diabetes mellitus in Korea

P2860

Q26739745-7C5B7144-82E6-4C37-B78A-C8E92E25B382 Q26801349-8C91B4E1-C14F-4D94-AB5E-B28B583E923E Q26859955-186499A4-8BA4-4F5A-8077-C0B357D41DF0 Q26995562-FD14AAC6-4FB8-4D52-8246-91C2517EB908 Q26996416-2432ACC0-A043-4B6B-A351-99CD9A61FE4C Q27011633-A903F679-3C80-416B-A147-0DEFD2F8CA84 Q27015663-87AE4206-82B6-4152-B4DF-CF7BABF0CED3 Q27028046-0E186253-8998-4F10-9A29-CC4DF13B930C Q28393087-947CD076-146B-4FBA-846F-55545F8822A3 Q28533621-CBF384F0-9522-4C88-9D81-09F95691DCE0 Q28534579-3471884C-4088-4FF6-97BA-C0A1745683FB Q28551366-E2BE2B32-DC91-4872-B384-3691C9641F81 Q30235132-AC7BEB9B-28AB-449A-BBA4-A35D7867F452 Q30238727-6156C972-83B7-4F51-991E-970343303B85 Q33575177-C6E06FA7-3CC4-4B77-B79D-C6DD2292D81D Q33583006-0F5685F4-7B00-4020-BF93-79E9DA505177 Q33594115-0826A5B7-7949-465B-895B-710377E23FA9 Q33621822-DC99271A-FDAE-48FE-BF18-FD79DA5C02CB Q33633642-A634AA29-A38A-4B38-A722-A5056FDB5869 Q33708002-9A535E94-E617-4AFD-9DED-7D59245FB3B7 Q33720211-63456CED-D65D-45A8-83E6-2F6A562EBB81 Q33860305-2A450F01-4578-491A-A1EA-505B95B89A4F Q33862382-1FDCE1E0-02B3-4852-B822-5326496E72CF Q33865342-F039799C-8F17-462C-83E0-7215EB86139C Q34275990-70B9EE85-C546-4D8D-977F-1219B58295AF Q34319638-D86939B9-3321-48B0-AECE-D8B6B7198313 Q34456265-D50D4F89-FFA7-44F0-81AA-642188A3963C Q34485306-1B0D9806-9E70-4C5E-89AB-9E809542BAF8 Q34720246-7F3AA20E-F01C-4B50-99C7-9EA09831EB1F Q34899309-1FCCF1F9-631F-46C0-B2E8-1B17E629554F Q35034925-C229C5FA-04C6-4A57-ADA2-751A57CD27AB Q35117107-E37A4709-7105-4828-A6A8-52CD39268945 Q35249711-7D43CBF7-2A04-4946-B47A-B96806C232E7 Q35535915-312974A0-EAAA-4E47-89F4-8CC8F67AD0F4 Q35557529-4A02D864-58EE-4907-BD1A-637C934108EE Q35558662-6F73BF41-8CB5-4074-BE05-E3021625147C Q35562478-3CB21806-2C75-4424-9AD8-2ADE8A70706B Q35669487-4489EB6C-9786-4C0F-BD78-7766335CCB4B Q35721856-139AFC22-ACCB-4E65-9DF7-5F4AFA81B098 Q35770061-BC527EFA-E541-4F2F-A0F0-F29F88E5CD89

P2860

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

http://www.wikidata.org/entity/Q37930962

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@en

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@nl

type

label

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@en

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@nl

prefLabel

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@en

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@nl

P1433

Q37930962-E75592A4-0FBB-48B9-A6E1-14B7A2CB9194

P1476

Q37930962-F00E41D7-9C07-40F1-AE34-53BB9CCCF60E

P2093

Q37930962-1ACF7964-10C3-480A-B555-074C308ED8B2

Q37930962-292AD90B-3403-4BA9-94CC-D25303721206

Q37930962-4C425186-5521-4D8E-923D-A3A6D5106D12

Q37930962-5274D0E3-9219-4B00-9B8B-8F7209F26433

P2860

Q37930962-04B6CACC-9F04-422E-A633-ABD0321B15D0

Q37930962-0AC9D504-44B0-4797-8C2E-5538CE7620CE

Q37930962-0BC1C7E9-D2A0-4F15-ADBD-0C181B5DC855

Q37930962-0BD8A643-F969-44C8-BED6-F17C8DCC2C28

Q37930962-0C3035A2-C213-44E8-A0FD-78498C407E9B

Q37930962-0CF90DC2-2B58-4014-BE75-9320EBE7E4E9

Q37930962-0FE8AF3C-4CC8-4EAE-A704-06406CE2A7C6

Q37930962-12F0F039-C868-4363-8E37-8C2A8E74C945

Q37930962-146DE0CF-9177-4287-BAC5-F7AF0FB9EF8F

Q37930962-1837303A-5337-4AD0-AFEE-6A4DE19131C3

P2888

Q37930962-2730ED91-BC2A-4728-B2BE-77F72109AF73

P304

Q37930962-8ED6F1BB-B2A8-46C3-9B6D-3956C70D71BA

P31

Q37930962-798885ED-A68D-4AEF-9033-7664B53BC845

P356

Q37930962-B5C4A82F-AA6A-43C6-933E-6BD5708939D0

P407

Q37930962-781BAD41-5754-4203-8318-6ACDDC48B510

P433

Q37930962-123F6A47-B56E-4AFB-8FAE-3C8B00FA7EA1

P478

Q37930962-85B20743-EFBE-4C29-BAAE-CDEEB7018239

P577

Q37930962-7214945B-489A-43E2-AC84-88A88207F30C

P698

Q37930962-37487214-7839-4131-B2FD-5C13787FAB33

P356

NRNEUROL.2011.137

P1433

Nature Reviews Neurology

P1476

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

@en

P2093

Andrea L Smith

http://www.w3.org/2001/XMLSchema#string

Andrea M Vincent

http://www.w3.org/2001/XMLSchema#string

Brian C Callaghan

http://www.w3.org/2001/XMLSchema#string

Eva L Feldman

http://www.w3.org/2001/XMLSchema#string

P2860

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Biochemistry and molecular cell biology of diabetic complications

Ranirestat for the management of diabetic sensorimotor polyneuropathy

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review

The multifaceted therapeutic potential of benfotiamine

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.

P2888

nrneurol.2011.137

P304

573-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2011.137

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21912405

http://www.w3.org/2001/XMLSchema#string